Details of the Drug

General Information of Drug (ID: DMU21JF)

Drug Name
AGS-009
Indication
Disease Entry ICD 11 Status REF
Systemic lupus erythematosus 4A40.0 Phase 1 [1]
Drug Type
Antibody
Cross-matching ID
TTD ID
D03BLG

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interferon alpha (IFNA) TT95SOA NOUNIPROTAC Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT00960362) An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE). U.S. National Institutes of Health.
2 Emerging Therapies for Systemic Lupus Erythematosus - Focus on Targeting Interferon-alpha. Clin Immunol. 2012 June; 143(3): 210-221.